How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Collagen for Healthcare Market
- By Source Type: Bovine Collagen, Porcine Collagen, Marine Collagen, Avian Collagen
- By Form: Powder, Capsules & Tablets, Liquid, Topical Creams & Gels
- By Application: Orthopedic Surgery, Wound Care, Dental Procedures, Cosmetic Surgery, Nutraceuticals
- By End User: Hospitals, Clinics, Dental Centers, Home Healthcare
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Bovine Collagen leads By Source Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 11 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 265 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.164 →
- 11 Company Profiles 11 players: SWOT & benchmarking p.172 →
Full report · locked preview
Everything inside the Collagen for Healthcare Market report
A complete, evidence-based study - 11 chapters and 111 sections covering market size, segmentation across 4 axes, regional analysis and 11 company profiles, forecast to 2033.
Segmentation covered
Source Type 4
Form 4
Application 5
End User 4
Companies profiled
Rousselot (Darling Ingredients)
Gelita AG
Nitta Gelatin Inc.
PB Leiner
Weishardt Group
Nippi Collagen
Collagen Solutions
Junca Gelatins
Capsugel (Lonza Group)
Gelnex
Rousselot
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
11 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Rousselot (Darling Ingredients)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Gelita AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Nitta Gelatin Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →PB Leiner
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Weishardt Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Nippi Collagen
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Collagen Solutions
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Junca Gelatins
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Capsugel (Lonza Group)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Gelnex
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Rousselot
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$10,505M by 2033 · 10.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Bovine Collagen60.6
- Porcine Collagen13.7
- Marine Collagen14.6
- Avian Collagen11.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,591M → $3,621M · 10.8%
Europe$1,109M → $2,318M · 9.7%
Asia Pacific$1,012M → $2,469M · 11.8%
Latin America$626.7M → $1,245M · 9.0%
Middle East and Africa$482.1M → $1,032M · 10.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.192026
10.182027
10.212028
10.212029
10.232030
10.242031
10.252032
10.262033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Rousselot (Darling Ingredients)15.8
- Gelita AG14.0
- Nitta Gelatin Inc.10.9
- PB Leiner11.1
- Weishardt Group10.9
- Nippi Collagen9.3
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Source Type17.3%
Form13.6%
Application42.7%
End User26.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.9
- Europe21.7
- Asia Pacific23.1
- Latin America11.7
- Middle East and Africa9.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Rousselot (Darling Ingredients) | 96 | 93 | 84 | 92 | 89 | 84 | 90 |
| Gelita AG | 71 | 89 | 92 | 80 | 83 | 82 | 83 |
| Nitta Gelatin Inc. | 84 | 85 | 83 | 76 | 84 | 69 | 80 |
| PB Leiner | 68 | 77 | 65 | 65 | 59 | 63 | 66 |
| Weishardt Group | 52 | 65 | 55 | 63 | 59 | 61 | 59 |
| Nippi Collagen | 48 | 67 | 56 | 47 | 47 | 46 | 52 |
| Collagen Solutions | 59 | 49 | 44 | 58 | 52 | 51 | 52 |
| Junca Gelatins | 54 | 53 | 57 | 38 | 45 | 44 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Rousselot (Darling Ingredients)
- Gelita AG
- Nitta Gelatin Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Rousselot (Darling Ingredients) | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Gelita AG | ◐ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Nitta Gelatin Inc. | ✓ | ✓ | ◐ | ◐ | ◐ | − |
| PB Leiner | ◐ | ◐ | − | ◐ | − | ◐ |
| Weishardt Group | − | − | − | − | ◐ | − |
| Nippi Collagen | − | ◐ | − | ◐ | ◐ | − |
| Collagen Solutions | ◐ | − | − | − | − | − |
| Junca Gelatins | ◐ | ◐ | ◐ | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Rousselot (Darling Ingredients)90
2Gelita AG83
3Nitta Gelatin Inc.80
4PB Leiner66
5Weishardt Group59
6Nippi Collagen52
7Collagen Solutions52
8Junca Gelatins49
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Rousselot (Darling Ingredients)Gelita AGNitta Gelatin Inc.
Contender2
Focused players with pockets of strength.
PB LeinerWeishardt Group
Niche3
Specialists in a single segment or region.
Nippi CollagenCollagen SolutionsJunca Gelatins
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Source Type in North America, then scale across Collagen for Healthcare Market — a $294M beachhead inside a $5.72B market.
Beachhead (SOM)$294Mobtainable near-term
Serviceable (SAM)$2.06Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Bovine Collagen
Best fit — highest urgency & budget in Source Type.
Economic buyer76 fit
Porcine Collagen
Strong fit — clear ROI and a fast path to value.
End user69 fit
Marine Collagen
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Source Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Form & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel28%
Digital / self-serve19%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Source Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Collagen for Healthcare Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified24%
Evaluation15%
Closed-won5%
$19.6KCAC
$116KLTV
5.9:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Collagen for Healthcare Market is a durable-growth opportunity — $5.09B by 2033, compounding at 9.8%.
TAM · 2025$2.41Btoday
TAM · 2033$5.09Bforecast
CAGR9.8%2027–2033
Cumulative$32.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.09BTotal addressable market
SAM$1.74BServiceable available market
SOM$357MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.8% CAGR
Demand compounds through 2033, outpacing GDP across Source Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Source Type moving from early to mainstream — durable secular demand.
Consolidation upside
11+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.09BLarge & growingTAM by 2033 at 9.8% CAGR
$1.74BServiceable nowreachable with today’s model
$357MBeachhead winobtainable near-term share
11+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.97BBear6.4% CAGR
$5.09BBase9.8% CAGR
$6.51BBull12.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Form optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Collagen for Healthcare Market — a $10.5B market by 2033. Plan: grow share from 10.4% to 17.5%.
Market size · 2033$10.5Btotal addressable
Market CAGR9.0%2027–2033
Target share17.5%from 10.4% today
Revenue ambition$1.83Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.4% | 17.5% | Behind |
| Revenue | $1.08B | $1.83B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 28.1% | 42.6% | At risk |
| Customer retention | 86.1% | 96.2% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Source Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Form capability
A defensible second engine — invest in Form to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Source Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Form
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $241M capacity & capability investment
- Greenlight bolt-on M&A in Form
- Authorise North America expansion plan
- Fund R&D program for Source Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Collagen for Healthcare Market conversation — a $8.63B market you can size, segment and defend in minutes.
Market size · 2033$8.63Btotal opportunity
Growth8.9%CAGR to 2033
Addressable buyers1,267+accounts in scope
Typical ROI5.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Source Type
Goal Grow share in Source Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.3×return on cost, year one
< 2 mopayback period
$66K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
11+players profiled in this market
Coverage includes
Rousselot (Darling Ingredients)Gelita AGNitta Gelatin Inc.PB LeinerWeishardt GroupNippi CollagenCollagen SolutionsJunca Gelatins+3 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Collagen for Healthcare Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Collagen for Healthcare Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Collagen Hybridizing Peptide (CHP) Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportCollagen Peptide Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportCollagen Supplements Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportCollagen Tripeptide Market
Collagen Tripeptide Market is valued at USD 895 Million in 2025 and is expected to reach USD 1.…
$895M market · 2025 base year
View reportCollagenase Solution Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportCollagen-Based Biomaterials Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportCollagen-Based Natural Sealant Market
Market size, share, segmentation and regional forecast.
$797M market · 2025 base year
View reportCollapsible Container Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportCollapsible Grip and Stand Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportCollapsible Rowing Machine Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportCollapsible Rowing Simulator Market
Market size, share, segmentation and regional forecast.
$524M market · 2025 base year
View reportCollapsible Tube Filling Machine Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.